Clinical Trial Update: ACCU-CHEK® Aviva Expert Study: Does Use of a Bolus Advisor Improve Glycemic Control in Patients Not Achieving Optimal Control Using Multiple Daily Injections (MDI)? [NA]

View source ↗

Summary

This clinical trial update describes results from the ACCU-CHEK Aviva Expert study evaluating whether a bolus advisor improves glycemic control in patients not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• ACCU-CHEK Aviva Expert Bolus Advisor

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | NA | Status: COMPLETED | Results posted: 2014-02-06